SCHEMBL25466802

SCHEMBL25466802

C=C(C)NCCCCCCCCCNC(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 6/20 0.41
KDM4E B2RXH2 1/20 0.39
MAPK1 P28482 1/20 0.39
HIF1A Q16665 1/20 0.39
HRH4 Q9H3N8 2/20 0.35
HRH3 Q9Y5N1 2/20 0.35
PAOX Q6QHF9 2/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
ADRA1A P35348 1/20 0.32
ADRB2 P07550 1/20 0.32
ALDH1A2 O94788 1/20 0.31
ALDH1A1 P00352 1/20 0.31
ALDH2 P05091 1/20 0.31
ALDH1A3 P47895 1/20 0.31
HTR1B P28222 1/20 0.31
NR2E1 Q9Y466 1/20 0.31
EPHX2 P34913 1/20 0.31
ZDHHC20 Q5W0Z9 1/20 0.31
ZDHHC2 Q9UIJ5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23841894 1.00 EPHX1 (0.41) EPHX1KDM4EMAPK1HIF1AHRH4
SCHEMBL27112936 0.93 EPHX1 (0.34) EPHX1KDM4EMAPK1HIF1AHRH4
SCHEMBL24103200 0.83 KDM4E (0.52) EPHX1KDM4EMAPK1HIF1APAOX
SCHEMBL22861675 0.81 EPHX1 (0.36) EPHX1KDM4EMAPK1HIF1AHRH4
SCHEMBL22861662 0.81 EPHX1 (0.36) EPHX1KDM4EMAPK1HIF1AHRH4
SCHEMBL23945439 0.81 EPHX1 (0.36) EPHX1KDM4EMAPK1HIF1AHRH4
SCHEMBL23945626 0.81 EPHX1 (0.36) EPHX1KDM4EMAPK1HIF1AHRH4
SCHEMBL25664913 0.79 EPHX1 (0.39) EPHX1KDM4EMAPK1HIF1AHRH4
SCHEMBL23451084 0.78 KDM4E (0.39) EPHX1KDM4EMAPK1HIF1APAOX
SCHEMBL24982532 0.78 HRH4 (0.35) KDM4EMAPK1HIF1AHRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081759-A1 BIFUNCTIONAL PI3K-ALPHA INHIBITORS AND USES THEREOF RELAY THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed